New tool aims to boost colon cancer screening in primary care
NCT ID NCT06625983
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial tested whether a decision support tool given before primary care visits helps more people get screened for colorectal cancer. Over 9,000 average-risk adults aged 45-75 who were overdue for screening took part. The tool was included in a pre-visit questionnaire to help patients make informed choices about screening methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CRC decision support tool
- What this could lead to
- If effective, this tool could help more people complete colorectal cancer screening, potentially catching cancer earlier and saving lives.
- What could go wrong
- The tool may not significantly increase screening rates, or its effect may vary across different patient groups. The trial is completed but results are not yet widely available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER CONTROL AND PREVENTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mass General Brigham
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple choice sheet curb unneeded opioid prescriptions?
- Giving patients a voice in methadone care: a new approach under the microscope
- Can a common laxative beat the standard prep for colon cancer screening?
- Could a simple water trick help more doctors screen for colon cancer?
- 3D lung models could help patients choose the right surgery
- New tool helps teens choose between two lifelong dental paths